AWA
Aaron Wealth Advisors’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
20,315
-1,367
| -6% | -$94.4K | 0.14% | 100 |
|
|
2025
Q1 | $1.51M | Buy |
21,682
+110
| +0.5% | +$7.64K | 0.17% | 84 |
|
|
2024
Q4 | $1.86M | Buy |
21,572
+1,396
| +7% | +$120K | 0.22% | 68 |
|
|
2024
Q3 | $2.4M | Buy |
20,176
+4,119
| +26% | +$490K | 0.29% | 54 |
|
|
2024
Q2 | $2.29M | Buy |
16,057
+1,708
| +12% | +$244K | 0.32% | 47 |
|
|
2024
Q1 | $1.84M | Buy |
14,349
+6,527
| +83% | +$838K | 0.26% | 58 |
|
|
2023
Q4 | $809K | Sell |
7,822
-18,960
| -71% | -$1.96M | 0.13% | 96 |
|
|
2023
Q3 | $2.44M | Buy |
26,782
+13,200
| +97% | +$1.2M | 0.31% | 51 |
|
|
2023
Q2 | $2.2M | Buy |
13,582
+167
| +1% | +$27K | 0.29% | 59 |
|
|
2023
Q1 | $2.13M | Buy |
13,415
+564
| +4% | +$89.8K | 0.29% | 54 |
|
|
2022
Q4 | $1.74M | Buy |
12,851
+326
| +3% | +$44.1K | 0.25% | 67 |
|
|
2022
Q3 | $1.25M | Buy |
12,525
+10,091
| +415% | +$1.01M | 0.23% | 68 |
|
|
2022
Q2 | $271K | Sell |
2,434
-209,338
| -99% | -$23.3M | 0.07% | 160 |
|
|
2022
Q1 | $1.91M | Buy |
+211,772
| New | +$1.91M | 0.03% | 242 |
|